A detailed history of Abrdn PLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Abrdn PLC holds 240,792 shares of ANIP stock, worth $20.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
240,792
Previous 269,678 10.71%
Holding current value
$20.2 Million
Previous $24.7 Million 18.1%
% of portfolio
0.03%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

SELL
$84.02 - $95.38 $2.43 Million - $2.76 Million
-28,886 Reduced 10.71%
240,792 $20.2 Million
Q3 2025

Nov 06, 2025

SELL
$63.35 - $98.81 $6.1 Million - $9.51 Million
-96,255 Reduced 26.3%
269,678 $24.7 Million
Q2 2025

Jul 24, 2025

SELL
$57.79 - $72.95 $3.07 Million - $3.88 Million
-53,166 Reduced 12.69%
365,933 $23.9 Million
Q1 2025

May 13, 2025

BUY
$53.93 - $68.36 $9.77 Million - $12.4 Million
181,134 Added 76.12%
419,099 $28.1 Million
Q4 2024

Jan 24, 2025

BUY
$53.35 - $61.74 $12.7 Million - $14.7 Million
237,965 New
237,965 $13.2 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.46B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.